Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy. [electronic resource]
Producer: 20190701Description: 2375-2376 p. digitalISSN:- 1533-4406
- Aged
- Alemtuzumab -- therapeutic use
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antineoplastic Agents, Immunological -- adverse effects
- Arrhythmias, Cardiac -- chemically induced
- Female
- Humans
- Melanoma -- drug therapy
- Myocarditis -- chemically induced
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.